Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient. The weight loss drug Wegovy could reduce the risk of cardiovascular disease based on the results of a trial, the company behind the drug said in […]
Author Archives: yun
09
Aug
Aug
New COVID-19 variants keep coming at us, fast and furious. Just two weeks ago, the XBB.1.5 variant accounted for the largest percentage of reported coronavirus cases in the United States (15.4 percent), according to the Centers for Disease Control and Prevention (CDC). But the latest numbers, published this week, show that the fast-spreading EG.5 variant […]
Advancing enrollment of TAMARACK Phase 2 study in metastatic castration-resistant prostate cancer (mCRPC) under revised protocol Initiating lorigerlimab Phase 2 study in mCRPC patients Achieved $50 million milestone related to Sanofi’s announcement of positive top-line data from TZIELD® (teplizumab-mzwv) type 1 diabetes study Conference call scheduled for today at 4:30 p.m. ET ROCKVILLE, Md., Aug. 09, […]
09
Aug
Aug
Women who conceived with assisted reproductive technology (ART) did not have worse long-term cardiovascular outcomes, according to a large Nordic registry-based study. Between those who gave birth with and without ART, risk of cardiovascular disease (CVD) was similar over a median 11 years of follow-up (adjusted HR 0.97, 95% CI 0.91-1.02), reported researchers led by […]
Expert Insight It takes a Village(MD): 2 key reasons Walgreens is a player to watch With a $6.2 billion investment in VillageMD, Walgreens is transforming the way healthcare is delivered to rural America. Here’s how the retail giant is using their acquisition strategy to expand access to primary, specialty, and urgent care.
09
Aug
Aug
Patients with chronic ischemic heart disease — an important cause of heart failure — show altered myocardial bioenergetics with metabolomic and transcriptomic changes that seem to occur at a global, rather than regional, level in human hearts. This is a preview of subscription content, access via your institution Access options Access through your institution Change […]
09
Aug
Aug
RESEARCH BRIEFINGS 09 August 2023 Analysis of immune responses to SARS-CoV-2 at single-cell resolution reveals marked differences across human populations that are caused by previous infections and genetic variation. Natural selection and past reproduction with Neanderthals contributed to these differing immune responses and disparities in COVID-19 risk.
Infection
Skin lesions by Scedosporium apiospermum and Nocardia pulmonary infection in an oncologic patient: a case report
09
Aug
Aug
Oncological patients are at a heightened risk of developing opportunistic infections, with approximately 80% of Nocardia infections occurring in immunocompromised individuals [2]. A review of 136 episodes of Nocardia infection at a cancer center revealed that 43.4% were associated with solid tumors, similar to our patient’s case, while the remainder were linked to haematological diseases […]
New York, Aug. 09, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Retinal Disorder Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F” – https://www.reportlinker.com/p06483156/?utm_source=GNW Global Retinal Disorder Treatment Market is expected to grow at an impressive rate during the forecast period on account of the increasing prevalence of […]
09
Aug
Aug
August 09, 2023 1 min read Source/Disclosures Published by: Source: Dao K. CVD and RA. Presented at: Rheumatology Nurses Society annual conference; August 2-5, 2023 (hybrid meeting). Disclosures: Dao reports financial disclosures with Pfizer. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive […]